Implementing precision oncology for sarcoma patients: the CCC(LMU)molecular tumor board experience

PURPOSE: Due to poor outcomes and limited treatment options, patients with advanced bone and soft tissue sarcomas (BS/STS) may undergo comprehensive molecular profiling of tumor samples to identify possible therapeutic targets. The aim of this study was to determine the impact of routine molecular p...

Descripción completa

Detalles Bibliográficos
Autores principales: Berclaz, Luc M., Burkhard-Meier, Anton, Lange, Philipp, Di Gioia, Dorit, Schmidt, Michael, Knösel, Thomas, Klauschen, Frederick, von Bergwelt-Baildon, Michael, Heinemann, Volker, Greif, Philipp A., Westphalen, C. Benedikt, Heinrich, Kathrin, Lindner, Lars H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590320/
https://www.ncbi.nlm.nih.gov/pubmed/37542550
http://dx.doi.org/10.1007/s00432-023-05179-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590320/
https://www.ncbi.nlm.nih.gov/pubmed/37542550
http://dx.doi.org/10.1007/s00432-023-05179-y

Ejemplares similares